We are excited to share with you our vision to spread an eye-tracking solution that offers clinical evaluation in a wink. We want to show you an innovation that aims to disrupt the current clinical practice of neurologists. See you soon in San Diego!
NeuroClues™, biomarkers in a blink.
For over 100 years, neuroscientists have studied eye movements, offering “a window to the workings of the brain” and helping identify neurological impairments such as Parkinson's Disease, Multiple Sclerosis, Traumatic Brain Injury, and Alzheimer's disease.
In the lack of easy-to-use equipment and appropriate training, oculomotor evaluation in the clinic is often basic.
We are developing NeuroClues™. A portable and easy-to-use eye-tracking environment to help practitioners instantaneously quantify their clinical exam. Developed to reach research-grade performance, it is designed to bring non-invasive, quick, and robust biomarkers. NeuroClues™ will enable:
- A better diagnosis thanks to its sensitivity for early detection and specificity for ruling out differential diagnosis
- A better follow-up of the patients with its objective measurements of the evolution of the disease and the efficacy of the treatment
- and a simple research tool
NeuroClues™ is a registered brand of P3Lab, currently under research and development phase. It will be available for sale when regulatory clearance is received.
Brands: NeuroClues™ brings the wealth of eye-tracking research to the clinic, helping objectively diagnose neurological diseases earlier. It provides non-invasive, quick, and robust biomarkers to assess clinical evaluation in a wink.